BARBON, Elena
 Distribuzione geografica
Continente #
NA - Nord America 852
EU - Europa 553
AS - Asia 210
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 1.621
Nazione #
US - Stati Uniti d'America 847
PL - Polonia 344
CN - Cina 95
IT - Italia 87
SG - Singapore 56
DE - Germania 36
UA - Ucraina 25
TR - Turchia 23
GB - Regno Unito 21
ID - Indonesia 16
FI - Finlandia 13
VN - Vietnam 13
BE - Belgio 12
SE - Svezia 10
CA - Canada 5
IR - Iran 3
EU - Europa 2
FR - Francia 2
AT - Austria 1
AZ - Azerbaigian 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
IN - India 1
KZ - Kazakistan 1
MY - Malesia 1
PE - Perù 1
RO - Romania 1
Totale 1.621
Città #
Warsaw 344
Fairfield 108
Woodbridge 102
Ann Arbor 72
Chandler 58
Ashburn 54
Wilmington 47
Santa Clara 46
Singapore 46
Houston 40
Ferrara 39
Seattle 34
Cambridge 33
Jacksonville 32
Nanjing 22
Beijing 21
Izmir 18
Jakarta 16
New York 14
Dong Ket 13
Princeton 13
Brussels 12
Shanghai 11
Milan 9
San Diego 9
Boardman 7
Bremen 7
Falls Church 7
Los Angeles 7
Dearborn 6
Falkenstein 6
Helsinki 6
Nanchang 6
Changsha 5
Florence 5
Cagliari 4
Des Moines 4
London 4
Shenyang 4
Toronto 4
Hebei 3
Munich 3
San Mateo 3
Ardabil 2
Auburn Hills 2
Augusta 2
Bovisio-Masciago 2
Guangzhou 2
Hounslow 2
Jinan 2
Leawood 2
Norwalk 2
Pearland 2
Piemonte 2
Almaty 1
Baku 1
Dundee 1
Edinburgh 1
Espoo 1
Ferrara di Monte Baldo 1
Fiume Veneto 1
Frankfurt am Main 1
Haikou 1
Hangzhou 1
Henderson 1
Islington 1
Jiaxing 1
Latina 1
Lima 1
Merano 1
Monmouth Junction 1
Mountain View 1
Newtonville 1
Ningbo 1
Noale 1
Orange 1
Ottawa 1
Paris 1
Persiceto 1
Phoenix 1
Porto Garibaldi 1
Redmond 1
Redwood City 1
Sabz 1
Saint Louis 1
Sassari 1
Shaoxing 1
Shenzhen 1
Spresiano 1
Taizhou 1
Washington 1
Yinchuan 1
Totale 1.364
Nome #
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 313
Development of cellular and animal models of coagulation factors deficiencies for the assessment of innovative therapeutic approaches acting on transcriptional and post-transcriptional regulation 221
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 179
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 162
Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function 153
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 143
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 113
Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model 104
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 96
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 70
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 55
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 55
Totale 1.664
Categoria #
all - tutte 7.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020146 0 0 0 0 0 0 26 25 29 30 24 12
2020/2021347 22 15 17 21 15 19 50 27 32 71 36 22
2021/2022128 9 17 3 6 2 7 9 2 8 16 3 46
2022/2023153 20 20 4 19 25 15 10 9 14 0 12 5
2023/202485 7 9 5 1 9 16 3 9 0 5 0 21
2024/2025175 7 9 36 17 46 54 6 0 0 0 0 0
Totale 1.664